Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry

Go back to Resources

Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry

Go back to Resources

Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry

Authors:

Location:

Go back to Resources

Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes

Go back to Resources

Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Severity of RSV LRI hospitalizations in 33 to 35 week and 36 week gestational age infants

Go back to Resources

Severity of RSV LRI hospitalizations in 33 to 35 week and 36 week gestational age infants

Authors:

Location:

Go back to Resources

Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans

Go back to Resources

Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

Go back to Resources

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for anemia during erythropoietin therapy among pediatric dialysis patients: a North American Pediatric Cooperative Study (NAPRTCS) Report

Go back to Resources

Risk factors for anemia during erythropoietin therapy among pediatric dialysis patients: a North American Pediatric Cooperative Study (NAPRTCS) Report

Authors:

Location:

Go back to Resources

Risk factors associated with age-related nuclear and cortical cataract - A case-control study in the age-related eye disease study. AREDS Report No. 5

Go back to Resources

Risk factors associated with age-related nuclear and cortical cataract - A case-control study in the age-related eye disease study. AREDS Report No. 5

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Subscribe to